Abstract
Although capsular polysaccharide-based vaccines are effective at reducing the incidence of meningococcal disease caused by serogroups A, C, Y, and W135 (1–3), immunization against serogroup B disease using similar strategies has proven unsuccessful (4,5). The primary reason for this is that the α2,8-linked N-acetylneuraminic acid homopolymer expressed by serogroup B strains is poorly immunogenic in humans (6). Consequently, considerable effort has been devoted towards the development of alternative strategies for vaccination against serogroup B disease. Many of these newer strategies include the use of lipooligosaccharide (LOS) as a protective antigen (7). One of the approaches that we are currently pursuing involves the use of synthetic oligopeptides to stimulate antibody responses that are cross-reactive with LOS antigens expressed by serogroup B Neisseria meningitidis strains. An integral part of these studies has been the application of combinatorial phage-display technology. Described here is an overview of the methods that we have utilized to identify peptide mimics of LOS epitopes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Twumasi, P. A., Jr., Kumah, S., Leach, A., O’Dempsey, T. J., Ceesay, S. J., Todd, J., et al. (1995) A trial of a group A plus group C meningococcal polysaccharide-protein conjugate vaccine in African infants. J. Infect. Dis. 171, 632–638.
Anderson, E. L., Bowers, T., Mink, C. M., Kennedy, D. J., Belshe, R. B., Harakeh, H., et al. (1994) Safety and immunogenicity of meningococcal A and C polysaccharide conjugate vaccine in adults. Infect. Immun. 62, 3391–3395.
Lieberman, J. M., Chiu, S. S., Wong, V. K., Partridge, S., Chang, S.-J., Chiu, C.-Y., et al. (1996) Safety and immunogenicity of a serogroups A/CNeisseria meningitidis oligosaccharide-protein conjugate vaccine in young children. JAMA 275, 1499–1503.
Wyle, F. A., Artenstein, M. S., Brandt, B. L., Tramont, E. C., Kasper, D. L., Altieri, P. L., et al. (1972) Immunologic response of man to group B meningococcal polysaccharide vaccines. J. Infect. Dis. 126, 514–521.
Granoff, D. M., Bartoloni, A., Ricci, S., Gallo, E., Rosa, D., Ravenscroft, N., et al. (1998) Bactericidal monoclonal antibodies that define unique meningococcal B polysaccharide epitopes that do not cross-react with human polysialic acid. J. Immunol. 160, 5028–5036.
Finne, J., Leinonen, M., and Makela, P. H. (1983) Antigenic similarities between brain components and bacteria causing meningitis; implications for vaccine development and pathogenesis. Lancet ii, 335–337.
Diaz Romero, J. and Outschoorn, I. M. (1994) Current status of meningococcal group B vaccine candidates: capsular or noncapsular? Clin. Microbiol. Rev. 7, 559–575.
Schneider, H., Hale, T. L., Zollinger, W. D., Seid, R. C., Hammack, C. A., and Griffiss, J. M. (1984) Heterogeneity of molecular size and antigenic expression within lipooligosaccharides of individual strains of Neisseria gonorrhoeae and Neisseria meningitidis. Infect. Immun. 45(3), 544–549.
Jennings, H. J., Beurret, M., Gamian, A., and Michon, F. (1987) Structure and immunochemistry of meningococcal lipopolysaccharides. Antonie van Leeuwenhoek 53, 519–522.
Jennings, H. J., Bhattacharjee, A. K., Kenne, L., Kenny, C. P., and Calver, G. (1980) The R-type lipopolysaccharides of Neisseria meningitidis. Can. J. Biochem. 58, 128–136.
Scholten, R. J., Kuipers, B., Valkenburg, H. A., Dankert, J., Zollinger, W. D., and Poolman, J. T. (1994) Lipo-oligosaccharide immunotyping of Neisseria meningitidis by a whole-cell ELISA with monoclonal antibodies. J. Med. Microbiol. 41, 236–243.
Tsai, C. M., Mocca, L. F., and Frasch, C. E. (1987) Immunotype epitopes of Neisseria meningitidis lipooligosaccharide types 1 through 8. Infect. Immun. 55, 1652–1656.
Tsai, C. M. and Civin, C. I. (1991) Eight lipooligosaccharides of Neisseria meningitidis react with a monoclonal antibody which binds lacto-N-neotetraose (Gal beta 1-4GlcNAc beta 1-3Gal beta 1-4Glc). Infect. Immun. 59, 3604–3609.
Mandrell, R. E., Griffiss, J. M., and Macher, B. A. (1988) Lipooligosaccharides (LOS) of Neisseria gonorrhoeae and Neisseria meningitidis have components that are immunochemically similar to precursors of human blood group antigens. J. Exp. Med. 168, 107–126.
Kahler, C. M., Martin, L. E., Shih, G. C., Rahman, M. M., Carlson, R. W., and Stephens, D. S. (1998) The (α2–8)-linked polysialic acid capsule and lipooligosaccharide structure both contribute to the ability of serogroup B Neisseria meningitidis to resist the bactericidal activity of normal human serum. Infect. Immun. 66, 5939–5947.
Estabrook, M. M., Griffiss, J. M., and Jarvis, G. A. (1997) Sialylation of Neisseria meningitidis lipooligosaccharide inhibits serum bactericidal activity by masking lacto-N-neotetraose. Infect. Immun. 65, 4436–4444.
Mackinnon, F. G., Borrow, R., Gorringe, A. R., Fox, A. J., Jones, D. M., and Robinson, A. (1993) Demonstration of lipooligosaccharide immunotype and capsule as virulence factors for Neisseria meningitidis using an infant mouse intranasal infection model. Microb. Pathog. 15, 359–366.
Jones, D. M., Borrow, R., Fox, A. J., Gray, S., Cartwright, K. A., and Poolman, J. T. (1992) The lipooligosaccharide immunotype as a virulence determinant in Neisseria meningitidis. Microb. Pathog. 13, 219–224.
Dalseg, R., Wedege, E., Holst, J., Haugen, I. L., Hoiby, E. A., and Haneberg, B. (1999) Outer membrane vesicles from group B meningococci are strongly immunogenic when given intranasally to mice. Vaccine 17, 2336–2345.
Fischer, M., Carlone, G. M., Holst, J., Williams, D., Stephens, D. S., and Perkins, B. A. (1999) Neisseria meningitidis serogroup B outer membrane vesicle vaccine in adults with occupational risk for meningococcal disease. Vaccine 17, 2377–2383.
Quakyi, E. K., Frasch, C. E., Buller, N., and Tsai, C. M. (1999) Immunization with meningococcal outer-membrane protein vesicles containing lipooligosaccharide protects mice against lethal experimental group B Neisseria meningitidis infection and septic shock. J. Infect. Dis. 180, 747–754.
Verheul, A. F., Braat, A. K., Leenhouts, J. M., Hoogerhout, P., Poolman, J. T., Snippe, H., and Verhoef, J. (1991) Preparation, characterization, and immunogenicity of meningococcal immunotype L2 and L3,7,9 phosphoethanolamine group-containing oligosaccharide-protein conjugates. Infect. Immun. 59, 843–851.
Glucksman, M. J., Bhattacharjee, S., and Makowski, L. (1992) Three-dimensional structure of a cloning vector. X-ray diffraction studies of filamentous bacteriophage M13 at 7 Å resolution. J. Mol. Biol. 226, 455–470.
Rasched, I. and Oberer, E. (1986) Ff coliphages: structural and functional relationships. Microbiol. Rev. 50, 401–427.
Russel, M. (1991) Filamentous phage assembly. Mol. Microbiol. 5, 1607–1613.
Makowski, L. (1993) Structural constraints on the display of foreign peptides on filamentous bacteriophages. Gene 128, 5–11.
Greenwood, J., Willis, A. E., and Perham, R. N. (1991) Multiple display of foreign peptides on a filamentous bacteriophage. Peptides from Plasmodium falciparum circumsporozoite protein as antigens. J. Mol. Biol. 220, 821–827.
De Bolle, X., Laurent, T., Tibor, A., Godfroid, F., Weynants, V., Letesson, J. J., and Mertens, P. (1999) Antigenic properties of peptidic mimics for epitopes of the lipopolysaccharide from Brucella. J. Mol. Biol. 294, 181–191.
Lowman, H. B. (1997) Bacteriophage display and discovery of peptide leads for drug development. Ann. Rev. Biophys. Biomol. Struct. 26, 401–424.
Lowman, H. B., Bass, S. H., Simpson, N., and Wells, J. A. (1991) Selecting high-affinity binding proteins by monovalent phage display. Biochemistry 30, 10,832–10,838.
Poolman, J. T., Kriz, Kuzemenska, P., Ashton, F., Bibb, W., Dankert, J., et al. (1995) Serotypes and subtypes of Neisseria meningitidis: results of an international study comparing sensitivities and specificities of monoclonal antibodies. Clin. Diagn. Lab. Immunol. 2, 69–72.
Van Dam, G. J., Verheul, A. F., Zigterman, G. J., De Reuver, M. J., and Snippe, H. (1989) Estimation of the avidity of antibodies in polyclonal antisera against Streptococcus pneumoniae type 3 by inhibition ELISA. Mol. Immunol. 26, 269–274.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Brett, P.J., Feavers, I.M., Charalambous, B.M. (2001). Identification of Peptides that Mimic N. meningitidis LOS Epitopes Via the Use of Combinatorial Phage-Display Libraries. In: Pollard, A.J., Maiden, M.C. (eds) Meningococcal Vaccines. Methods in Molecular Medicine™, vol 66. Humana Press. https://doi.org/10.1385/1-59259-148-5:181
Download citation
DOI: https://doi.org/10.1385/1-59259-148-5:181
Publisher Name: Humana Press
Print ISBN: 978-0-89603-801-1
Online ISBN: 978-1-59259-148-0
eBook Packages: Springer Protocols